5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer — Stella

Recruiting

Back to Superficial Basal Cell Carcinoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Boston Medical Center Dermatology Clinic, Boston, Massachusetts

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Boston University

Enrollment target

~200 participants

Started

October 2022

Primary completion

June 2027

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov